EDMOND DE ROTHSCHILD HOLDING S.A. - PLURISTEM THERAPEUTICS INC ownership

PLURISTEM THERAPEUTICS INC's ticker is PSTI and the CUSIP is 72940R102. A total of 37 filers reported holding PLURISTEM THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 0.05 and the average weighting 0.0%.

Quarter-by-quarter ownership
EDMOND DE ROTHSCHILD HOLDING S.A. ownership history of PLURISTEM THERAPEUTICS INC
ValueSharesWeighting
Q2 2019$2,000
-50.0%
4,0000.0%0.00%
Q1 2019$4,000
+33.3%
4,0000.0%0.00%
Q4 2018$3,000
-40.0%
4,0000.0%0.00%
Q3 2018$5,0000.0%4,0000.0%0.00%
Q2 2018$5,0000.0%4,0000.0%0.00%
Q1 2018$5,0000.0%4,0000.0%0.00%
Q4 2017$5,000
-16.7%
4,0000.0%0.00%
Q3 2017$6,000
+20.0%
4,0000.0%0.00%
Q2 2017$5,0004,0000.00%
Other shareholders
PLURISTEM THERAPEUTICS INC shareholders Q1 2018
NameSharesValueWeighting ↓
Penserra Capital Management LLC 13,802$8,145,0000.80%
SABBY MANAGEMENT, LLC 251,020$404,0000.02%
Psagot Value Holdings Ltd. 87,987$142,0000.01%
OPPENHEIMER & CO INC 103,000$166,0000.01%
Renaissance Technologies 1,006,800$1,621,0000.00%
Mosaic Family Wealth, LLC 2,500$4,0000.00%
Harel Insurance Investments & Financial Services Ltd. 7,000$11,0000.00%
BARCLAYS PLC 818,673$819,0000.00%
GROUP ONE TRADING, L.P. 28,002$45,0000.00%
VAN ECK ASSOCIATES CORP 85,603$138,0000.00%
View complete list of PLURISTEM THERAPEUTICS INC shareholders